Articles published by Comera Life Sciences
Comera Life Sciences Announces Process Exploring Strategic Alternatives
December 06, 2023
From Comera Life Sciences
Via GlobeNewswire
Tickers
CMRA
Comera Life Sciences Appoints Dorothy Clarke to Board of Directors
November 13, 2023
From Comera Life Sciences
Via GlobeNewswire
Tickers
CMRA
Comera Life Sciences Reports Financial Results for Third Quarter 2023 and Recent Business Highlights
November 09, 2023
From Comera Life Sciences
Via GlobeNewswire
Tickers
CMRA
Comera Life Sciences Presents SQore™ Platform Technology Data at PODD: Partnerships in Drug Delivery Conference
October 16, 2023
From Comera Life Sciences
Via GlobeNewswire
Tickers
CMRA
Comera Life Sciences Announces Publication of Study Reinforcing Caffeine’s Viscosity Reducing Capabilities
August 16, 2023
From Comera Life Sciences
Via GlobeNewswire
Tickers
CMRA
Comera Life Sciences Reports Financial Results for Second Quarter 2023 and Recent Business Highlights
August 10, 2023
From Comera Life Sciences
Via GlobeNewswire
Tickers
CMRA
Comera Life Sciences Announces $4.1 Million Private Placement
August 01, 2023
From Comera Life Sciences
Via GlobeNewswire
Tickers
CMRA
Comera Life Sciences Announces Expansion of Patent Portfolio Underlying Core Excipient Technology
April 03, 2023
From Comera Life Sciences
Via GlobeNewswire
Tickers
CMRA
Comera Life Sciences to Present at 22nd Annual PepTalk Conference
January 12, 2023
From Comera Life Sciences
Via GlobeNewswire
Tickers
CMRA
Comera Life Sciences Closes $3.6 Million Private Placement Priced At-the-Market under Nasdaq Rules
January 04, 2023
From Comera Life Sciences
Via GlobeNewswire
Tickers
CMRA
Comera Life Sciences to Participate in the Benchmark Company’s Upcoming Discovery One-on-One Investor Conference
November 17, 2022
From Comera Life Sciences
Via GlobeNewswire
Tickers
CMRA
Comera Life Sciences Reports Financial Results for Third Quarter 2022 and Business Highlights
November 10, 2022
From Comera Life Sciences
Via GlobeNewswire
Tickers
CMRA
Comera Life Sciences Announces Favorable Preclinical Results of Lead SQore Excipient in SEQURUS-2 Study
October 18, 2022
From Comera Life Sciences
Via GlobeNewswire
Tickers
CMRA
Comera Life Sciences Expands Woburn Operations
October 04, 2022
From Comera Life Sciences
Via GlobeNewswire
Tickers
CMRA
ReForm Biologics Changes Name to Comera Life Sciences
January 27, 2022
From Comera Life Sciences
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.